Spots Global Cancer Trial Database for Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children

The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.

Trial Identification

Brief Title: Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children

Official Title: Co-administration of Propofol and Remifentanil for Lumbar Puncture in Children: Evaluation of Two Dose Combinations

Study ID: NCT00405522

Conditions

Spinal Puncture

Interventions

Propofol 2.0 mg/kg + Remifentanil 1.5 ug/kg

Propofol 4.0 mg/kg + Remifentanil 0.5 ug/kg

Study Description

Brief Summary: The objective of this study is to compare intraoperative and recovery parameters in patients who receive two different dose combinations of propofol and remifentanil in patients undergoing a lumbar puncture.

Detailed Description: Lumbar punctures (LP) are performed in approximately one thousand oncology patients per year at the Hospital for Sick Children. In a previous study, we determined the optimal dose of remifentanil which provides effective anesthesia with little or no movement during LP in children. The present study will determine the optimal dose combination of propofol and remifentanil to keep patients comfortable and still during the procedure while decreasing the incidence of side effects and allows for shorter recovery times and earlier discharge from the recovery room.